Neuroendocrine tumours trials in China

In China 62 Also abroad 244

62 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.
Where
Wuhan
Age
18 years and over
People
60
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT05747729
Phase 1Taking people
Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients
Where
Beijing
Age
18 years to 75 years
People
9
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07366658
No phaseTaking people
Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms
Where
Changchun
Age
18 years and over
People
483
Run by
Jilin University
See details and how to joinNCT07612748
Phase 3Taking people
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
Where
Shanghai, Tianjin
Age
18 years to 75 years
People
220
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT05884255
Phase 3Not yet taking people in China
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
Where
Zhengzhou
Age
18 years to 75 years
People
240
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07595913
Phase 2/3Taking people
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Where
Beijing
Age
18 years and over
People
298
Run by
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT07165886
No phaseTaking people
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Where
Shanghai
Age
18 years and over
People
21
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06141369
Phase 2Not yet taking people in China
A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma
Where
Beijing
Age
18 years to 75 years
People
23
Run by
Beijing GoBroad Hospital
See details and how to joinNCT07520357
Phase 2Taking people
Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma
Where
Guangzhou
Age
18 years to 75 years
People
34
Run by
Sun Yat-sen University
See details and how to joinNCT07518602
Phase 2Not yet taking people in China
A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC
Where
Tianjin
Age
18 years to 75 years
People
48
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07510594
No phaseTaking people
Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
Where
Chengdu, Shanghai
Age
18 years and over
People
1,000
Run by
Fudan University
See details and how to joinNCT05847855
Phase 1/2Taking people
A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma
Where
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Luoyang, Nanchang, Nanning, Shanghai, Shenyang, Taiyuan, Wuhan, Xiangyang, Zhengzhou
Age
18 years to 75 years
People
178
Run by
Nanjing Leads Biolabs Co.,Ltd
See details and how to joinNCT06157827
No phaseTaking people
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
Where
Wuhan
Age
18 years and over
People
500
Run by
Huazhong University of Science and Technology
See details and how to joinNCT07463872
Phase 1Taking people
A Study of FZ-AD005 in Patients With Advanced Solid Tumors
Where
Changsha, Hangzhou, Shanghai
Age
18 years to 75 years
People
162
Run by
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
See details and how to joinNCT06424665
No phaseTaking people
AI-Powered Precision Decision-Making for Pancreatic Diseases
Where
Shanghai
Age
18 years to 80 years
People
2,000
Run by
Changhai Hospital
See details and how to joinNCT07439757
Phase 2Taking people
Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
Where
Beijing, Hefei, Shanghai, Zhengzhou
Age
18 years to 75 years
People
96
Run by
Shanghai Chest Hospital
See details and how to joinNCT07357623
Phase 1/2Taking people
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Where
Zhengzhou
Age
18 years to 75 years
People
54
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT05978284
Phase 1/2Taking people
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Where
Guanzhou
Age
18 years to 70 years
People
350
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07038096
Phase 4Taking people
Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms
Where
Shanghai
Age
18 years and over
People
350
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07272512
Phase 2Taking people
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma
Where
Chengdu, Nanjing, Shanghai, Tianjin, Xi’an
Age
18 years to 75 years
People
22
Run by
RenJi Hospital
See details and how to joinNCT06091124
Phase 2Taking people
Ivonescimab in the Treatment of Multiple Advanced Tumors
Where
Shanghai
Age
18 years and over
People
400
Run by
Fudan University
See details and how to joinNCT06683846
Phase 1Taking people
A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens
Where
Beijing
Age
18 years to 80 years
People
36
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT06732505
Phase 4Not yet taking people in China
A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma
Where
Beijing
Age
18 years and over
People
45
Run by
Beijing GoBroad Hospital
See details and how to joinNCT07014540
No phaseNot yet taking people in China
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
Where
Xi'an
Age
18 years to 80 years
People
20
Run by
Xijing Hospital
See details and how to joinNCT07014254
No phaseTaking people
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Where
Nanjing
Age
18 years to 75 years
People
20
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06937112